+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transfection Reagents & Equipment Market by Product Type, Technology Type, Molecule Type, Transfection Mode, Application - Global Forecast 2026-2032- Product Image
Transfection Reagents & Equipment Market by Product Type, Technology Type, Molecule Type, Transfection Mode, Application - Global Forecast 2026-2032- Product Image
Sale

Transfection Reagents & Equipment Market by Product Type, Technology Type, Molecule Type, Transfection Mode, Application - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4985963
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transfection Reagents & Equipment Market is projected to reach USD 1.60 Billion in 2026. It is expected to continue growing at a CAGR of 7.18%, reaching USD 2.43 Billion by 2032.

The transfection reagents and equipment landscape is central to modern life sciences because it enables nucleic acids, proteins, and gene-editing systems to enter cells for discovery, biomanufacturing, and therapeutic development. Demand is supported by sustained scientific activity in cell and gene therapy, RNA therapeutics, vaccine research, oncology, immunology, and functional genomics, where reproducible delivery into primary cells, stem cells, immune cells, and difficult-to-transfect cell lines remains a critical workflow requirement.

Market momentum is reinforced by the clinical validation of nucleic acid-based medicine. Regulatory approvals for mRNA vaccines, CAR-T therapies, adeno-associated virus gene therapies, and the first CRISPR-based therapy approvals in major markets have increased the need for reliable transfection technologies across research, process development, and quality-controlled manufacturing environments. As a result, suppliers are differentiating through higher cell viability, lower cytotoxicity, scalable electroporation platforms, animal-origin-free chemistries, closed-system compatibility, and application-specific protocols for cell therapy, biologics, and synthetic biology workflows.

Transformative Shifts in the Landscape

The transfection reagents and equipment market is shifting from general-purpose laboratory transfection toward application-specific, scalable, and regulatory-aligned delivery solutions. Lipid-based transfection reagents remain widely used for plasmid DNA, siRNA, mRNA, and protein-expression workflows, while electroporation and nucleofection continue gaining relevance for primary cells, T cells, natural killer cells, induced pluripotent stem cells, and other hard-to-transfect systems. This shift reflects the industry’s need to balance transfection efficiency with cell viability, phenotype preservation, and downstream functionality.

Another transformative change is the convergence of research tools with manufacturing-ready transfection platforms. Cell therapy developers increasingly require closed, automated, and GMP-compatible delivery systems that reduce contamination risk and operator variability. At the same time, academic and contract research laboratories are prioritizing workflow simplicity, data reproducibility, and reagent consistency as high-throughput screening, CRISPR knockout libraries, transient protein production, and viral vector development expand across translational research programs.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing transfection workflows by improving experimental design, protocol optimization, and quality prediction. Machine learning models can analyze cell type, nucleic acid payload, reagent ratio, pulse parameters, viability readouts, and expression outcomes to recommend optimized conditions faster than traditional trial-and-error approaches. This is particularly valuable for primary cells, immune cells, stem cells, and patient-derived samples, where limited material availability makes experimental efficiency commercially and clinically important.

AI also supports supplier competitiveness by accelerating formulation development, enabling predictive maintenance for electroporation instruments, improving automated image-based assessment of transfection efficiency, and strengthening digital quality control in cell processing workflows. As laboratories connect instruments, laboratory information management systems, electronic lab notebooks, and imaging platforms, AI-enabled analytics can reduce variability, improve documentation, and support more reproducible transfection outcomes in regulated and non-regulated environments.

Key Regional Insights

Asia-Pacific is becoming a major hub for transfection reagents and equipment as China, Japan, South Korea, India, Australia, and ASEAN markets expand investments in biotechnology, vaccine platforms, biologics, genomics, and cell therapy research. China’s large biopharma base and active clinical research environment support demand for scalable nucleic acid delivery tools, while Japan and South Korea’s advanced life sciences infrastructure favor premium reagents, precision instruments, and regenerative medicine workflows. India is strengthening cost-efficient research, biologics production, and contract development capabilities, and Australia supports clinical translation through strong biomedical research networks and regulated advanced therapy programs. Across Southeast Asia, growing public and private investment in life sciences is improving access to molecular biology platforms and training-driven adoption.

North America remains a leading center of adoption, anchored by the United States and Canada’s concentration of pharmaceutical research, academic medical centers, NIH-supported biomedical science, clinical-stage cell and gene therapy developers, and specialized contract development and manufacturing organizations. Europe benefits from strong research networks, the European Medicines Agency framework, and established life science clusters in Germany, France, the United Kingdom, Italy, Spain, and the Nordics, with demand shaped by advanced therapy development, biomanufacturing standards, and cross-border research collaboration. Latin America, led by Brazil and Mexico, is showing gradual uptake through academic research, biosimilar development, vaccine capabilities, and public health biotechnology initiatives. The Middle East, especially GCC countries, is investing in genomics, precision medicine, and national biotechnology strategies, while Africa’s opportunity is linked to expanding molecular biology capacity, vaccine research partnerships, genomic surveillance, and public health laboratories.

Key Group Insights

ASEAN is gaining relevance as Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines expand biomedical research infrastructure, with Singapore serving as a regional anchor for translational science, clinical research, and bioprocessing. Demand across ASEAN is supported by rising investment in university laboratories, diagnostic modernization, vaccine research, and regional contract research capabilities. The GCC is building demand through healthcare diversification, genomics programs, precision medicine initiatives, and national science strategies in Saudi Arabia, the United Arab Emirates, Qatar, and neighboring markets, where imported high-performance platforms are often favored for advanced research environments.

The European Union provides a large, regulation-driven environment for transfection technologies through coordinated research funding, cross-border clinical development, advanced therapy medicinal product regulation, and strong biomanufacturing standards. BRICS economies are important for volume growth because Brazil, Russia, India, China, and South Africa combine large patient populations, expanding domestic biotechnology, and growing research capacity, although procurement models, regulatory alignment, and supply chain access vary by country. The G7 remains a premium demand center due to advanced pharmaceutical R&D, deep venture funding, established academic ecosystems, and mature clinical translation infrastructure. NATO-aligned countries add resilience through investments in biosecurity, pandemic preparedness, medical countermeasures, and dual-use biotechnology infrastructure, all of which require reliable nucleic acid delivery workflows.

Key Country Insights

The United States leads demand through its concentration of cell and gene therapy developers, leading universities, life science tool users, and FDA-regulated clinical translation pathways, supported by extensive public and private biomedical research. Canada contributes through strong academic research, regenerative medicine networks, and clinical manufacturing initiatives, while Mexico is building capabilities in biomedical research, pharmaceutical production, and nearshore life science supply chains. Brazil is the primary Latin American opportunity due to its large healthcare system, public research institutions, vaccine capabilities, and biologics infrastructure.

In Europe, the United Kingdom remains influential in genomics, advanced therapies, and academic spinouts; Germany combines engineering strength with biopharma manufacturing and precision instrumentation adoption; France supports immunology, oncology, vaccine, and cell therapy research; Italy and Spain contribute through translational medicine networks, hospital-based research, and growing advanced therapy capabilities; and Russia maintains scientific capability despite geopolitical and supply chain constraints that affect access to specialized reagents and equipment. In Asia-Pacific, China is scaling rapidly in biopharma, gene editing, and cell therapy; India is expanding cost-competitive research, biosimilars, vaccines, and biologics production; Japan emphasizes high-quality regenerative medicine, iPSC research, and precision tools; Australia supports clinical translation, biomedical research, and early-phase advanced therapy studies; and South Korea is advancing cell therapy, biologics, vaccine platforms, and contract development capabilities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize application-specific portfolios that address distinct workflows for mRNA delivery, CRISPR editing, transient protein expression, viral vector production, and immune cell engineering. Competitive advantage will come from validated protocols, high-viability performance in difficult cell types, GMP-compatible documentation, lot-to-lot consistency, and systems that move smoothly from discovery to process development and clinical manufacturing.

Companies should also invest in automation, closed-system compatibility, digital protocol libraries, and AI-enabled optimization tools that reduce user variability. Regional strategies should combine premium platforms for North America, Europe, Japan, and South Korea with cost-effective, training-supported offerings for India, Southeast Asia, Latin America, the Middle East, and Africa. Partnerships with contract development and manufacturing organizations, academic core facilities, hospitals, and cell therapy centers can accelerate adoption and generate application data that strengthens technical credibility.

Research Methodology

This executive summary is developed through a structured secondary research approach aligned with market intelligence best practices. The analysis considers publicly available regulatory records, scientific literature, clinical trial activity, government biotechnology initiatives, documented life science funding programs, and adoption patterns across research, therapeutic development, and biomanufacturing workflows.

Insights are validated by triangulating demand signals from peer-reviewed research activity, clinical approvals in nucleic acid and cell-based therapies, regional biotechnology investments, and innovation in lipid reagents, polymer-based reagents, electroporation, nucleofection, and automated transfection systems. The methodology emphasizes evidence-based interpretation rather than speculative market sizing, ensuring that conclusions remain grounded in observable industry developments and verifiable technology adoption trends.

Conclusion

Transfection reagents and equipment are no longer limited to routine laboratory support; they are enabling technologies for genetic medicine, cell therapy, synthetic biology, protein production, viral vector development, and advanced disease modeling. As therapeutic modalities become more complex and cell types more specialized, the landscape is moving toward precision delivery, reproducibility, scalability, automation, and regulatory readiness.

Suppliers that combine high-performance chemistries, robust electroporation platforms, AI-guided optimization, GMP-aligned workflows, and regionally tailored commercial strategies will be best positioned to address evolving demand. The strongest opportunities will emerge where scientific validation, manufacturing scalability, workflow integration, and reliable technical support converge across global life science ecosystems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Transfection Reagents & Equipment Market, by Product Type
7.1. Transfection Reagents
7.1.1. Lipid-based Transfection Reagents
7.1.2. Polymer-Based Reagents
7.1.3. Calcium Phosphate Reagents
7.2. Transfection Equipment
7.2.1. Electroporation Systems
7.2.2. Microinjection Systems
8. Transfection Reagents & Equipment Market, by Technology Type
8.1. Chemical Methods
8.2. Physical Methods
8.3. Viral Methods
9. Transfection Reagents & Equipment Market, by Molecule Type
9.1. Plasmid DNA
9.2. shRNA
9.3. mRNA
9.4. CRISPR-Cas9 RNP complexes
9.5. Oligonucleotides
10. Transfection Reagents & Equipment Market, by Transfection Mode
10.1. Transient Transfection
10.2. Stable Transfection
10.3. Episomal Expression Systems
11. Transfection Reagents & Equipment Market, by Application
11.1. Gene Expression Studies
11.2. Protein Production
11.3. Drug Discovery & Development
11.4. Gene Therapy & Cell Therapy
11.5. Vaccine Development
12. Asia-Pacific Transfection Reagents & Equipment Market
13. North America Transfection Reagents & Equipment Market
14. Latin America Transfection Reagents & Equipment Market
15. Europe Transfection Reagents & Equipment Market
16. Middle East Transfection Reagents & Equipment Market
17. Africa Transfection Reagents & Equipment Market
18. ASEAN Transfection Reagents & Equipment Market
19. GCC Transfection Reagents & Equipment Market
20. European Union Transfection Reagents & Equipment Market
21. BRICS Transfection Reagents & Equipment Market
22. G7 Transfection Reagents & Equipment Market
23. NATO Transfection Reagents & Equipment Market
24. United States Transfection Reagents & Equipment Market
25. Canada Transfection Reagents & Equipment Market
26. Mexico Transfection Reagents & Equipment Market
27. Brazil Transfection Reagents & Equipment Market
28. United Kingdom Transfection Reagents & Equipment Market
29. Germany Transfection Reagents & Equipment Market
30. France Transfection Reagents & Equipment Market
31. Russia Transfection Reagents & Equipment Market
32. Italy Transfection Reagents & Equipment Market
33. Spain Transfection Reagents & Equipment Market
34. China Transfection Reagents & Equipment Market
35. India Transfection Reagents & Equipment Market
36. Japan Transfection Reagents & Equipment Market
37. Australia Transfection Reagents & Equipment Market
38. South Korea Transfection Reagents & Equipment Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Agilent Technologies, Inc.
40.2. Altogen Biosystems
40.3. Becton, Dickinson and Company
40.4. Bio-Rad Laboratories, Inc.
40.5. Bio-Techne Corporation
40.6. Biontex Laboratories GmbH
40.7. Celetrix LLC
40.8. GeneCopoeia Inc.
40.9. Lonza Group AG
40.10. MaxCyte, Inc.
40.11. Merck KGaA
40.12. Mirus Bio LLC
40.13. Novogene Corporation
40.14. OriGene Technologies, Inc.
40.15. Polyplus-transfection SA
40.16. Promega Corporation
40.17. QIAGEN N.V.
40.18. Revvity
40.19. Roche Holding AG
40.20. Sartorius AG
40.21. SignaGen Laboratories
40.22. Takara Bio Inc.
40.23. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TRANSFECTION REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TRANSFECTION REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TRANSFECTION REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL LIPID-BASED TRANSFECTION REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL LIPID-BASED TRANSFECTION REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL LIPID-BASED TRANSFECTION REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL POLYMER-BASED REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL POLYMER-BASED REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL POLYMER-BASED REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CALCIUM PHOSPHATE REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CALCIUM PHOSPHATE REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CALCIUM PHOSPHATE REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TRANSFECTION EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TRANSFECTION EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TRANSFECTION EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ELECTROPORATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ELECTROPORATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ELECTROPORATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MICROINJECTION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MICROINJECTION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MICROINJECTION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CHEMICAL METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CHEMICAL METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CHEMICAL METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PHYSICAL METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PHYSICAL METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PHYSICAL METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VIRAL METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VIRAL METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VIRAL METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PLASMID DNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PLASMID DNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PLASMID DNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SHRNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SHRNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SHRNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MRNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MRNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MRNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CRISPR-CAS9 RNP COMPLEXES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CRISPR-CAS9 RNP COMPLEXES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CRISPR-CAS9 RNP COMPLEXES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL TRANSIENT TRANSFECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL TRANSIENT TRANSFECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TRANSIENT TRANSFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL STABLE TRANSFECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL STABLE TRANSFECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL STABLE TRANSFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL EPISOMAL EXPRESSION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL EPISOMAL EXPRESSION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL EPISOMAL EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENE EXPRESSION STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENE EXPRESSION STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENE EXPRESSION STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PROTEIN PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PROTEIN PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PROTEIN PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENE THERAPY & CELL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENE THERAPY & CELL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENE THERAPY & CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 108. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 109. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 110. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 124. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 125. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 126. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 127. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 128. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 129. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 133. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 134. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 135. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 137. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 140. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 141. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 142. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 143. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 144. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 145. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 157. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 158. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 159. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 160. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 161. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 165. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 166. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 167. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 168. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 169. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 173. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 174. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 175. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 176. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 177. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 187. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 189. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 190. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 191. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 192. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 193. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 195. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 197. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 198. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 199. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 200. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 201. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 203. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 205. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 206. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 207. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 208. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 209. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 211. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 213. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 214. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 215. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 216. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 217. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 219. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 221. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 222. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 223. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 224. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 225. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 229. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 230. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 231. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 232. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 233. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 235. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 237. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 238. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 239. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 240. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 241. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 244. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 245. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 246. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 247. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 248. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 249. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 250. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 251. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 252. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 253. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 254. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 255. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 256. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 257. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 258. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 259. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 260. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 261. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 262. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 263. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 264. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 265. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 266. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 267. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 268. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 269. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 270. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 271. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 272. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 273. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 275. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 276. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 277. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 278. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 279. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 280. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 281. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 282. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 283. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 284. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 285. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 286. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 287. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 288. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 289. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 290. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 291. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 292. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2018-2032 (USD MILLION)
TABLE 293. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 294. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 295. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 296. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2018-2032 (USD MILLION)
TABLE 297. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Transfection Reagents & Equipment market report include:
  • Agilent Technologies, Inc.
  • Altogen Biosystems
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biontex Laboratories GmbH
  • Celetrix LLC
  • GeneCopoeia Inc.
  • Lonza Group AG
  • MaxCyte, Inc.
  • Merck KGaA
  • Mirus Bio LLC
  • Novogene Corporation
  • OriGene Technologies, Inc.
  • Polyplus-transfection SA
  • Promega Corporation
  • QIAGEN N.V.
  • Revvity
  • Roche Holding AG
  • Sartorius AG
  • SignaGen Laboratories
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.6 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.43 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Transfection Technologies Market - Global Forecast 2026-2032 - Product Image

Transfection Technologies Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Cell Transfection System Market - Global Forecast 2025-2030 - Product Image

Cell Transfection System Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Transfection Reagents and Equipment - Global Strategic Business Report - Product Image

Transfection Reagents and Equipment - Global Strategic Business Report

  • Report
  • 330 Pages
  • Global
From
Transfection Technologies - Global Strategic Business Report - Product Image

Transfection Technologies - Global Strategic Business Report

  • Report
  • 221 Pages
  • Global
From
Transfection Reagents and Equipment Market Report 2026 - Product Image

Transfection Reagents and Equipment Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.